Roxane Laboratories, Inc. has received the approval of their Abbreviated New Drug Application for Acarbose Tablets, 25mg, 50mg, and 100mg.

Roxane Laboratories, a subsidiary of Boehringer Ingelheim Corporation  marketing  over 75 medications in nearly 250 package sizes, focusing on an expanding line of multisource pharmaceutical products including: bulk and unit-dose liquids and solids; coated, sustained-release and controlled-release tablets; nasal sprays, cytotoxics and CII narcotics.

Acarbose Tablets is available in bottles of 100 tablets for all strengths as well as Unit Dose Blisters for the 50mg strength and is available for immediate shipment to wholesalers and pharmacies.